Natural psychedelic drug discovery and extraction company Filament Health has today announced a collaboration with UCSF’s recently-launched TrPR Program. TrPR, the Translational Psychedelic Research Program, is led by Dr. Joshua Woolley. The interdisciplinary network of researchers provides expertise spanning neuroscience, multiple medical specialties, nursing, and psychology. As part of the…


Previous articleCan Psychedelics Help Heal Moral Injury?
Next articleHorizons ETFs Announces Methodology Update for the North American Psychedelics Index